| BCBS Louisiana | cysteamine ophthalmic solution 0.37% (Cystadrops®) | 2026-03-01 |
| BCBS Louisiana | Brexafemme® (ibrexafungerp) | 2026-03-01 |
| BCBS Louisiana | Pharmacotherapy for Pompe Disease | 2026-03-01 |
| BCBS Louisiana | avacopan (Tavneos™) | 2026-03-01 |
| BCBS Louisiana | Loreev XR® (lorazepam extended release) | 2026-03-01 |
| BCBS Louisiana | Select Ursodiol Products | 2026-03-01 |
| BCBS Louisiana | efgartigimod alfa (Vyvgart®), efgartigimod alfa and hyaluronidase- human (Vyvgart® Hytrulo) | 2026-03-01 |
| BCBS Louisiana | Auvelity® (dextromethorphan/bupropion) | 2026-03-01 |
| BCBS Louisiana | palovarotene (Sohonos™) | 2026-03-01 |
| BCBS Louisiana | Irreversible Electroporation and Histotripsy | 2026-03-01 |